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doi:10.1016/S1078-5884(08)00144-5, available online at http://www.sciencedirect.com onSelected Abstracts from the May Issue of the Journal of Vascular Surgery*A single-center experience treating renal malperfusion after aortic
dissection with central aortic fenestration and renal artery stenting
Dawn M. Barnes, David M. Williams, Narasimham L. Dasika, Himanshu J.
Patel, Alan B. Weder, James C. Stanley, G. Michael Deeb and Gilbert R.
Upchurch
Objective. Patients with aortic dissection were studied to define (1) anatomic
and physiologic derangements in renal artery blood flow, (2) differences in
clinically suspected renal malperfusion and true functional malperfusion,
and (3) variations in endovascular interventions for the treatment of renal
malperfusion.
Methods. The cohort comprised 165 patients (mean age, 58 years) with dissec-
tions who were thought to have malperfusion sufficient to require arteriogra-
phy. They were treated from 1996 to 2004 for acute (n = 115) or chronic (n = 50)
aortic dissections (75 had type A, 90 had type B lesions). All patients had sus-
pected peripheral vascular malperfusion (ie, cerebral, spinal, mesenteric, re-
nal, or lower extremity vascular beds). Renal malperfusion was suspected
in 88 patients secondary to worsening hypertension (n = 34), evolving renal
insufficiency (n = 37), computed tomography evidence of impaired renal
blood flow (n = 13), or a combination of factors (n = 4). Patients underwent
angiographic and intravascular ultrasound studies. Renal malperfusion was
confirmed with a systolic gradient between the aortic root and renal hilum
(average, 44 mm Hg).
Results. Right renal arteries arose exclusively from the true lumen in 115
patients (70%), the false lumen in 11 (7%), and both lumens in 37 (23%).
Left renal arteries arose exclusively from the true lumen in 69 patients (42%),
the false lumen in 32 (20%), and both lumens in 62 (38%). Angiographic con-
firmation of malperfusion existed in 59 patients (67%) of the 88 suspected of
such, and in 31 patients (39%) of the 79 with suspected of nonrenal tissues.
Of the 90 patients with confirmed renal malperfusion, 71 underwent endo-
vascular therapy including isolated renal artery stenting (n = 31), as well as
proximal aortic fenestration with or without aortic stenting (n = 24), or both
renal and aortic intervention (n = 16). Residual pressure gradients averaged
8.1 mm Hg after these interventions. Five procedure-related complications
(7%) occurred. The periprocedural postintervention mortality rate was 21%
(n = 15), including multisystem organ failure (n = 7), false lumen rupture
(n = 3), reperfusion injury (n = 2), cerebral ischemia (n = 1), cardiac arrest
(n = 1), and unknown (n = 1).
Conclusions. Percutaneous aortic fenestration and renal artery stenting are
both technically feasible and associated with an acceptable complication
rate. Most patients respond well symptomatically, obviating the need for
immediate surgical relief of renal artery obstruction and allowing for renal
malperfusion recovery.Five-year results of endovascular treatment with the Gore TAG device
compared with open repair of thoracic aortic aneurysms
Michel S. Makaroun, Ellen D. Dillavou, Grayson H. Wheatley and Richard P.
Cambria
Objectives. Report the results of a phase II multicenter, prospective trial com-
paring endovascular treatment of descending thoracic aneurysm (TEVAR)
with the TAG device to surgical controls after 5 years of follow-up.
Methods. The Gore TAG trial compared the TAG endograft patients (n = 140)
with standard open surgical controls (n = 94) with enrollment from Septem-
ber of 1999 to May of 2001. An additional 51 patients were enrolled in 2003
after revision of the endograft. Follow-up consisted of patient visits, com-
puted tomography (CT) scans and x-rays at 1, 6, and 12 months and yearly.
Significant sac size change was defined as 5 mm increase or decrease
from the 1 month baseline measurement. Migration was defined as 10
mm cranial or caudal movement of the device inside the aorta. Significance
was determined as P  .05.YEJVS3165_3170_proof 
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at 2.8% compared with open controls at 11.7% (P = .008). No differences in
all-cause mortality were noted, with 68% of TAG patients and 67% of open
controls surviving to 5 years (P = .43). Major adverse events at 5 years were
significantly reduced in the TAG group; 57.9% vs 78.7% (P = .001). Endoleaks
in the TAG group decreased from 8.1% at 1 month to 4.3% at 5 years. Five
TAG patients have undergone major aneurysm-related re-interventions at 5
years (3.6%), including one arch aneurysm repair for type 1 endoleak and mi-
gration, one open conversion and five endovascular procedures for endoleaks
in three patients. There were fewer secondary procedures not directly related
to aneurysm repair in the TAG vs the open repair group at 5 years, 15.0% vs
31.9%, (P = .01). For TAG patients, sac size at 60 months decreased in 50% and
increased in 19% compared with the 1-month baseline. Comparison with the
modified low-porosity device at 24 months showed sac increase in 12.9% of
original vs 2.9% in modified grafts (P = .11). At 5 years, there have been no
ruptures, one migration, no collapse, and 20 instances of fracture in 19 pa-
tients, all before the revision of the TAG graft.
Conclusions. In anatomically suitable patients, TAG treatment of thoracic an-
eurysms is superior to surgical repair at 5 years. Although sac enlargement is
concerning, early modified device results indicate this issue may be resolved.Midterm outcomes of femoral arteries after percutaneous endovascular
aortic repair using the Preclose technique
W. Anthony Lee, Michael P. Brown, Peter R. Nelson, Thomas S. Huber and
James M. Seeger
Objective. Percutaneous access during endovascular aortic repair has been
shown to be feasible and safe using a suture-mediated closure device (‘‘Pre-
close’’ technique) for closure of up to 24F introducer sheaths. The purpose of
this study is to examine the late outcomes of those femoral arteries repaired
in this manner.
Methods. The Preclose technique has been previously described. Briefly, the
technique involves two Perclose Proglide devices deployed in the femoral
artery prior to insertion of the large diameter introducer sheath and then
closure of the arteriotomy by tying down knots of the Proglide following
removal of the sheath. The medical records of all patients who underwent
endovascular aortic repairs using the Preclose technique between December
2004 and August 2007 were reviewed. Follow-up protocol consisted of com-
puted tomography (CT) angiograms performed at 1, 6, and 12 months, and
annually thereafter. All Preclose patients who had at least a 6-month post-
operative scan were included in the study. For each patient, the most recent
postoperative scan was compared with the preoperative scan for evidence of
any new anatomic abnormalities of the femoral artery such as dissection, ste-
nosis, or pseudoaneurysm. Three-dimensional post processing with multipla-
nar reconstructions was also performed as necessary to confirm axial scan
findings.
Results. A total of 292 patients underwent percutaneous endovascular aortic
repairs (TEVAR-125, EVAR-167). Four hundred thirty-two femoral arteries
were closed with 870 devices. Four hundred eighteen vessels were approx-
imated with two devices, while 30 arteries required three devices for hemo-
stasis and an additional four vessels only required a single device. Two
hundred seventy-eight (64.3%) vessels were accessed with sheaths 18 to
24F. Four hundred eight femoral arteries (94.4%) were closed successfully
with the Preclose technique. There were 100 patients (TEVAR-35, EVAR-
65) who had adequate postoperative CT scan at 6-months or later. The
mean follow up was 11.65.0 months. Of the 156 femoral arteries in these
100 patients repaired using the Preclose technique, there were 3 late compli-
cations in 3 patients, 1 asymptomatic femoral artery dissection, and 2 fem-
oral artery pseudoaneurysms requiring surgical repair, resulting in a late
complication rate of 1.92% (3/156).
Conclusion. Percutaneous closure of femoral arteries after large diameter in-
troducer sheaths using the Preclose technique has a low incidence of early
and late complications related to the closure site.4 April 2008  625/627
f European Society for Vascular Surgery.
626 AbstractsPatients with head and neck cancers and associated postirradiated
carotid blowout syndrome: Endovascular therapeutic methods and
outcomes
Feng-Chi Chang, Jiing-Feng Lirng, Chao-Bao Luo, Shuu-Jiun Wang, Hsiu-Mei
Wu, Wan-Yuo Guo, Michael Mu Huo Teng and Cheng-Yen Chang
Purpose. This study retrospectively evaluated the technical and hemostatic
outcomes of reconstructive and deconstructive endovascular management
in patients with head and neck cancers associated with carotid blowout syn-
drome (CBS).
Methods. Twenty-four patients with head and neck cancers with CBS involv-
ing the main trunk of carotid artery underwent endovascular therapy. This
included reconstructive management with self-expandable stent grafts to pre-
serve the diseased carotid artery in 11 patients and deconstructive manage-
ment with balloons, coils, or acrylic adhesives to occlude the diseased
carotid artery in 13 patients. Based on clinical severity and therapeutic prior-
ity, we classified CBS in our patients into two groups: acute or impending and
threatened. The angiographic severity was graded from 0 to 3. Evaluation of
technical outcome included technical success, initial and delayed complica-
tions, and patency of stent graft in the reconstructive group. The hemostatic
outcome was evaluated by immediate hemostatic result, rebleeding, and
duration of hemostasis. Sex, age, clinical and angiographic severities, local
wound complications, and location of the pathologic lesion were examined
as predictors of the technical and hemostatic outcomes of endovascular man-
agement by using Cox regression method.
Results. Technical success and immediate hemostasis were achieved in all
patients of both groups. Initial complications during the procedures were
encountered in four patients (36.4%) who underwent reconstructive man-
agement and in one patient (7.7%) who underwent deconstructive manage-
ment (P = .142). Delayed complications during the follow-up were seen in
one patient (9.1%) with reconstructive management and one patient
(7.7%) with deconstructive management (P¼ .99). Rebleeding occurred in
five patients (45.5%) in the reconstructive management group and in three
patients (23.1%) in the deconstructive management group (P = .659). The
mean duration of hemostasis after initial reconstructive and deconstructive
management was 4.0 8.1 and 8.5 10.1 months, respectively (P = .249). Re-
bleeding was noted in 7 of 11 patients (63.6%) with acute CBS and in 1 of 13
patients (7.7%) with impending and threatened CBS (P = .008).
Conclusion. There is no significant difference in technical and hemostatic
outcomes between the reconstructive and deconstructive endovascular man-
agement methods. Hemostatic results were influenced by clinical severity.
The rebleeding rate is higher in patients with advanced and acute clinical
severity.Infrapopliteal arterial revascularization for critical limb ischemia: Is the
peroneal artery at the distal third a suitable outflow vessel?
Enzo Ballotta, Giuseppe Da Giau, Mario Gruppo, Franco Mazzalai and Bruno
Martella
Purpose. Though the peroneal artery (PA) often remains patent despite dis-
ease or occlusion of other infrapopliteal arteries, there is skepticism about us-
ing the terminal PA as the outflow tract in distal revascularizations for limb
salvage, especially when a patent inframalleolar artery is available. We ana-
lyzed our experience of using the distal PA and inframalleolar or pedal
branches arteries as outflow tracts in revascularizations for critical limb
ischemia.
Methods. Over a decade, among 651 infrapopliteal arterial reconstructions
performed in 597 patients, the PA was the outflow vessel in 214, its distal
third being involved in 69 vein revascularizations (study group). During
the same period, 187 vein bypass grafts were performed to 179 inframalleolar
and 8 pedal branches arteries (control group). Patency, limb salvage and sur-
vival rates were assessed using Kaplan-Meier life-table analysis. Complete
follow-up (range, 0.1e10.2 years; mean, 5.8 years) was obtained in 245
(95.7%) patients (66 were in the study group).
Results. The distal PA was chosen as the target vessel: (1) because the prox-
imal, mid-PA was occluded or severely diseased and no other adequate
inframalleolar or pedal branches arteries were identified preoperatively
(n = 30; 43.5%); (2) because an alternative inframalleolar target vessel was
present but severely diseased (n = 9; 13%); (3) because of the lengthEur J Vasc Endovasc Surg Vol 35, May 2008limitations of the available vein (n = 12; 17.4%; or (4) because of the pres-
ence of invasive infection or necrosis overlying the dorsalis pedis or poste-
rior tibial arteries (n = 18; 26.1%). The study group was significantly
younger than the control group (68 7 years vs 70 6 years, P = .039),
and included significantly more patients with diabetes mellitus (65.2% vs
50.2%, P = .033) and insulin dependence (52.2% vs 37.9%, P = .041), dialy-
sis-dependent chronic kidney disease (5.8% vs 1.1%, P = .047), and history
of smoking (75.3% vs 58.2%, P = .012). None of the patients died in the peri-
operative period. Although the overall need for minor amputation was sta-
tistically higher in the PA group (78.2% vs 63.1%, P = .022), especially as
concerns partial calcanectomy (8.7% vs 2.1%, P = .026), the proportion of
wounds completely healed during the follow-up and the mean time to
wound healing were comparable in the two groups. Kaplan-Meier analysis
showed comparable long-term patency, limb salvage, and survival rates in
the two groups.
Conclusions. Revascularization to the distal third of the PA can achieve much
the same outcome in terms of patency and limb salvage rates, wound healing
rate and timing, as when other inframalleolar or pedal branches are used. The
skepticism surrounding use of the terminal PA as an outflow vessel appears
to be unwarranted.Infrainguinal vein graft stenosis: Cutting balloon angioplasty as the first-
line treatment of choice
Peter A. Schneider, Michael T. Caps and Nicolas Nelken
Objective. The optimal treatment for hemodynamically significant infraingui-
nal vein bypass graft stenosis is not known. This study compares three op-
tions as first choice for the revision of failing infrainguinal vein grafts:
cutting balloon angioplasty (CBA), standard percutaneous transluminal bal-
loon angioplasty (PTA), and open surgical revision (OS).
Methods. Infrainguinal vein bypass graft lesions treated in a single institution
during a 12-year period were evaluated. Of these, 161 lesions in 124 infrain-
guinal bypasses (101 patients) were treated with OS (n = 42), PTA (n = 57), or
CBA (n = 62). The initial indication for the bypass in these patients was limb
salvage in 73% and claudication in 27%. The primary outcome of interest was
the development of vein graft occlusion or significant stenosis (70%) as de-
tected by surveillance duplex ultrasound scanning or arteriography some
time after repair.
Results. The stenosis-free patency rates at 48 months for OS, CBA, and PTA
were 74%, 62%, and 34%, respectively. PTAwas associated with an increased
risk of treatment failure compared with both OS (hazard ratio [HR], 3.9;
P< .0001) and CBA (HR, 3.1; P< .0001). There was no significant difference
between OS and CBA (HR, 1.3 for CBA vs OS, P = .6). Pseudoaneurysms de-
veloped in two CBA patients. One ruptured and required interposition graft,
and one was monitored.
Conclusion. Cutting balloon angioplasty is a reasonable, initial treatment for
infrainguinal vein graft stenosis in most patients. It is a safe, minimally inva-
sive, outpatient procedure with patency rates that are comparable to OS and
superior to PTA.Contemporary outcomes after superficial femoral artery angioplasty and
stenting: The influence of TASC classification and runoff score
Daniel M. Ihnat, Son T. Duong, Zachary C. Taylor, Luis R. Leon, Joseph L.
Mills Sr, Kaoru R. Goshima, Jose A. Echeverri and Bulent Arslan
Objective. A recent randomized trial suggested nitinol self-expanding stents
(SES) were associated with reduced restenosis rates compared with simple
percutaneous transluminal angioplasty (PTA). We evaluated our results
with superficial femoral artery (SFA) SES to determine whether TransAtlantic
InterSociety Consensus (TASC) classification, indication for intervention, pa-
tient risk factors, or Society of Vascular Surgery (SVS) runoff score correlated
with patency and clinical outcome, and to evaluate if bare nitinol stents or ex-
panded polytetrafluoroethylene (ePTFE) covered stent placement adversely
impacts the tibial artery runoff.
Methods. A total of 109 consecutive SFA stenting procedures (95 patients)
at two university-affiliated hospitals from 2003 to 2006 were identified.
627AbstractsMedical records, angiographic, and noninvasive studies were reviewed
in detail. Patient demographics and risk factors were recorded. Procedural
angiograms were classified according to TASC Criteria (I-2000 and II-2007
versions) and SVS runoff scores were determined in every patient;
primary, primary-assisted, secondary patency, and limb salvage rates were
calculated. Cox proportional hazard model was used to determine if
indication, TASC classification, runoff score, and comorbidities affected
outcome.
Results. Seventy-one patients (65%) underwent SES for claudication and 38
patients (35%) for critical limb ischemia (CLI). Average treatment length
was 15.7 cm, average runoff score was 4.6. Overall 36-month primary, pri-
mary-assisted, and secondary rates were 52%, 64%, and 59%, respectively.
Limb salvage was 75% in CLI patients. No limbs were lost following inter-
ventions in claudicants (mean follow-up 16 months). In 24 patients with
stent occlusion, 15 underwent endovascular revision, only five (33%) ulti-
mately remained patent (15.8 months after reintervention). In contrast, all
nine reinterventions for in-stent stenosis remained patent (17.8 months).
Of 24 patients who underwent 37 endovascular revisions for either occlu-
sion or stenosis, eight (35%) had worsening of their runoff score (4.1 to
6.4). By Cox proportional hazards analysis, hypertension (HR 0.35), TASC
D lesions (HR 5.5), and runoff score> 5 (HR 2.6) significantly affected
primary patency.
Conclusions. Self-expanding stents produce acceptable outcomes for treat-
ment of SFA disease. Poorer patency rates are associated with TASC D lesions
and poor initial runoff score; HTN was associated with improved patency
rates. Stent occlusion and in-stent stenosis were not entirely benign; one-third
of patients had deterioration of their tibial artery runoff. Future studies of
SFA interventions need to stratify TASC classification and runoff score. Fur-
ther evaluation of the long-term effects of SFA stenting on tibial runoff is
needed.Effect of prolonged treatment with compression stockings to prevent
post-thrombotic sequelae: A randomized controlled trial
Markus Aschwanden, Christina Jeanneret, Michael T. Koller, Christoph
Thalhammer, Heiner C. Bucher and Kurt A. Jaeger
Objective. Compression stockings arewidelyappliedafter acuteproximaldeep
vein thrombosis, but their efficacy in preventing the post-thrombotic syndrome
remains controversial. This study assessed the effect of prolonged compression
therapyafter a standard treatment of 6months after acutedeepvein thrombosis.
Methods. Of 900 patients screened, we randomly allocated 169 patients with
a first or recurrent proximal deep vein thrombosis after receiving 6 months of
standard treatment to wear compression stockings or not. Primary efficacy
analysis was performed on the end point of emerging skin changes (C4-C6
according to the CEAP classification). Secondary analysis was done on symp-
toms associated with post-thrombotic syndrome. All analyses were done
according to the intention-to-treat principle.
Results. The primary end point occurred in 11 patients (13.1%) in the treatment
group compared with 17 (20.0%) in the control group (hazard ratio [HR], 0.60;
95% confidence interval [CI], 0.28-1.28; P = .19). Mean follow-up was 3.2 years
and 2.9 years, respectively. Five additional patients in the control group re-
quired compression therapy owing to post-thrombotic signs and symptoms
not included in the primary end point. No venous ulceration was observed
in either group. Within subgroup analyses of the primary end point, we ob-
served a large sex-specific difference between women (HR, 0.11; 95% CI, 0.02-
0.91) and men (HR, 1.07; 95% CI, 0.42-2.73). Symptom relief was significant in
favor of compression treatment during the first year but not thereafter.
Conclusion. Prolonged compression therapy after proximal deep vein throm-
bosis significantly reduces symptoms and may prevent post-thrombotic skin
changes. Whether these findings translate to the prevention of advanced dis-
ease states with ulcerations remains unclear.Eur J Vasc Endovasc Surg Vol 35, May 2008
